Word: uclaf
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...middle, until recently, was the drug's producer, France's Roussel Uclaf. Its corporate parent, Germany's huge Hoechst chemical company, feared a pro-life boycott of its American products if it allowed RU 486 to be marketed in the U.S. And Yorkin threatened a pro-choice boycott if it didn't. In the face of this dilemma and some badgering by the FDA, the company did what a typically cautious multinational would: it passed its burden (or tried to, anyway) onto the shoulders of someone else, in this case the nonprofit Population Council...
...President Clinton, who supports abortion rights, the Food and Drug Administration first dropped its opposition to the French-developed pill. Now comes another step. After years of refusing even to seek American permission to market its product out of fear of becoming enmeshed in the abortion controversy, manufacturer Roussel Uclaf has agreed to license the pill to the Population Council, based in New York City...
...approval process at the Food and Drug Administration -- if someone would put in an application. The drug has few side effects, is safer than surgical abortion, and is very effective for ending a pregnancy in the first trimester. Though RU 486 would be a big seller, French manufacturer Roussel Uclaf has avoided seeking approval in the U.S. Reason: the militant antiabortion movement, which had supporters in Presidents Reagan and Bush...
With Bill Clinton in charge, Roussel Uclaf may be reconsidering. Its president, Edouard Sakiz, met with FDA Commissioner David Kessler and agreed in principle that the U.S. should have RU 486. Sakiz prefers that another firm handle distribution. If he finds one, a large clinical trial could soon begin...
...then introducing RU 486, the so-called abortion pill, into the U.S. ranks second. So far the foes of abortion have managed to keep the French-made drug out of the country. But last week a delegation of American feminists and scientists met in Paris with executives of Roussel Uclaf, the French company that manufactures the drug, and in Frankfurt with officials * from Hoechst AG, Roussel's parent company. The Americans presented a petition signed by 115,000 people urging the distribution of RU 486 in the U.S. American support for the drug has also been growing rapidly among physicians...